With Terrana Biosciences, Moderna founder Flagship can apply its RNA knowledge to agricultural use cases like pest and ...

AI is reshaping life sciences. Learn how compliant, explainable, and genuinely useful systems move from pilot to scale and ...

More billionaire immigrants come from India than anywhere else in the world followed by two much smaller spots tied at number ...

Despite the Trump administration’s efforts to shrink the FDA, Senate appropriators unanimously advanced a funding bill ...

PhaseV, a leader in AI/ML-driven clinical development, today announced the appointment of Melanie Ivarsson OBE, PhD, to the ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

Armenia’s AI leap, backed by its diaspora, has sparked a regional tech race, with Türkiye eyeing a strategic response ...

Terrana is aiming to have commercially available products in the next few years, pending regulatory approval, that can be applied as sprayables or seed treatments. And the company says its RNA-based ...

Trump administration policy tug-of-war between big medical groups that want COVID vaccines back on CDC schedule for healthy ...

Global recognition affirms Tyme’s mission to serve entire populations and unlock human potential through digital banking. Tyme Group, the major ...

Carney claimed he had only cash and real estate holdings, and it turns out he held hundreds of stocks, stock options and ...